Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial - Publikation - Autoren - KSSG Forschungsdatenbank

Publikation

Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial

Wissenschaftlicher Artikel/Review - 16.01.2006

Rothermundt Christian, Hubner R, Ahmad T, Gibbens I, Keyzor C, Habeshaw T, Kaye S, Gore M

Rothermundt, Christian

Leitender Arzt
Leitung Ambulatorium St.Gallen & Rorschach
Medizinische Onkologie und Hämatologie · Dept. I

Hubner, R

Ahmad, T

Gibbens, I

Keyzor, C

Habeshaw, T

Kaye, S

Gore, M